News

Children in the United States will be able to avoid potentially millions of hours of at-home quarantining under a testing program unveiled by the CDC today.

The proposed funding will include a number of measures of spending towards HIV and prevention, including community centers for PrEP education.

The CDC is recommending the Pfizer-BioNTech and Moderna COVID-19 vaccines over Janssen’s, due to 57 cases of a rare blood clotting condition.

Side effects that occur during concurrent vaccine administrations can influence future vaccine decisions.

A review of the data and circumstances that led to authorization in children ages 5 to 11 years.

Clinical trial compares immunogenicity of mixing mRNA, adenoviral and spike-adjuvant vaccines in 2-dose series against COVID-19.

Antimicrobial resistance is “the silent pandemic,” Dr. Leonard Friedland says, and vaccines are how we fight it.

The website, LearnAntibiotics.com, is a supplemental tool offering guides, practice exams, and other resources to help students, residents, or practicing professionals with infectious diseases pharmacotherapy.

Hospitalists can be better equipped to identify patients most in need of intervention and standardize sepsis management efforts.

A clinical trial of 8 sub-Saharan African countries will be the first to study the efficacy of mRNA COVID-19 vaccination in people living with HIV.

A personal history of cervical cancer or cervical biopsy did not make mothers more likely to vaccinate their children against HPV.

A study's results may have implications for future virus tracking.

Patients with severe COVID-19 who received high-flow oxygen therapy were less likely to need mechanical ventilation and had a shorter time to clinical recovery, investigators in Colombia found.

Christian Lillis, co-founder and executive director of the Peggy Lillis Foundation (PLF) for C diff Education & Advocacy, says that taking care of each other is often the best way to stop the spread of infectious diseases.

A once-weekly treatment for deadly fungal infections from Cidara Therapeutics and Mundipharma, rezafungin demonstrated positive results in its phase 3 clinical trial.

The company believes the pill should work against the Omicron variant.

A reflection on the wins and setbacks in the second year of our pandemic, 2021.

The federal agency will provide $22 million in funding to organizations worldwide dedicated to identifying next crisis.

A novel digital pill was 98% effective in tracking daily HIV PrEP adherence.

HPV vaccination decreases cervical cancer incidence and mortality, but it is most effective in young women and girls.

Community-based models of antiretroviral therapy were as effective as facility-based care in terms of viral suppression, the study authors wrote.

Recent study results show promising new modalities.

A booster dose of the m-RNA vaccine reduced COVID-19 and the rates of severe illness across adult age groups.

New cohort data from VA medical centers provide more evidence of a correlate between antibody levels and vaccine effectiveness for mRNA vaccines.

Clinical and public health laboratories reported increased influenza virus detections over the past few weeks, but US cases remains comparatively low to previous flu seasons.

The CDC updated its HIV PrEP guidelines, including a recommendation that doctors talk to all sexually active adults about HIV prevention and prescribe PrEP to anyone who asks for it.

An Israeli study found that a third “booster” shot of the Pfizer-BioNTech vaccine reduced the risk of COVID-19 death by 90%.

Here is a look at some of the treatment alternatives, which can offer simpler logistics and cost considerations.